<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04819152</url>
  </required_header>
  <id_info>
    <org_study_id>Rökstoppsprojektet</org_study_id>
    <secondary_id>Dnr: 2019-02221</secondary_id>
    <secondary_id>2017-01681</secondary_id>
    <nct_id>NCT04819152</nct_id>
  </id_info>
  <brief_title>Effectiveness of Tobacco Cessation Interventions in Sweden</brief_title>
  <acronym>RSP</acronym>
  <official_title>Effectiveness of Tobacco Cessation Interventions for Different Groups of Users in Sweden: a National Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lund University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Smoking is still one of the most important risk factors causing morbidity and mortality in&#xD;
      Sweden. Every year, 12,000 Swedish citizens die prematurely from smoking, and smoking is&#xD;
      responsible for up to 60% of the inequity in health.&#xD;
&#xD;
      Though the smoking prevalence is relatively low in Sweden in an international context (8% and&#xD;
      10% for men and women respectively in 2016), specific vulnarable groups have a very high&#xD;
      prevalence; e.g. about 80% in alcohol and drug abusers. Furthermore, Sweden has a unique high&#xD;
      prevalence of snus users and in 2016 the daily use of tobacco was 25% for men and 14% for&#xD;
      women. In addition, products such as cigarettes, snus, and e-cigettes are often mixed.&#xD;
&#xD;
      Despite the fact that about a thousand counsellors have been trained in manual-based&#xD;
      person-centred tobacco cessation interventions in Sweden, the effectiveness of the&#xD;
      interventions remains unknown, as a follow-up on effect of in-person interventions is not&#xD;
      systematically collected in Sweden. Therefore, as of today it is not possible, on a national&#xD;
      level, to compare the effectiveness of differences in these interventions, providers, or&#xD;
      different groups of tobacco users including disadvantaged and vulnerable groups.&#xD;
&#xD;
      In this study the investigators will evaluate the effectiveness of already implemented&#xD;
      in-person cessation interventions targeting smoking, use of snus and/or e-cigarettes,&#xD;
      focusing on disadvantaged and vulnerable groups of tobacco users. Furthermore, important&#xD;
      factors associated with a successful outcome after controlling for confounders will be&#xD;
      identified (in relation to programme, patients and setting).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>% of patients that are continuously smokefree</measure>
    <time_frame>6 months</time_frame>
    <description>Self-reported smoking status, questionnaire completed by telephone interview</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>% of patients that are smokefree</measure>
    <time_frame>On completion of the tobacco cessation programme (app. 1 month after quitting)</time_frame>
    <description>Counsellor observed smoking status, questionnaire completed by counsellor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of patients that have been smokefree for at least the latest 14 days</measure>
    <time_frame>6 months</time_frame>
    <description>Self-reported smoking status, questionnaire completed by telephone interview</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of patients that are satisfied with the smoking cessation intervention</measure>
    <time_frame>6 months</time_frame>
    <description>Self-reported patient-satisfaction, questionnaire completed by telephone interview</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">8000</enrollment>
  <condition>Tobacco Use</condition>
  <condition>Smoking</condition>
  <condition>Cigarette Use, Electronic</condition>
  <arm_group>
    <arm_group_label>Exposed</arm_group_label>
    <description>Several studies will be performed based on this cohort. I each study the exposed group will be a group of tobacco users evaluatedin the relevant study. This could be a vulnarable group tobacco users such as: users without a job, with short or no education, without permanent housing, diagnosed with mental illness, diagnosed with chronic obstructive pulmonary disease (COPD), undergoing surgery, adolescents, elderly, migrants, or pregnant women.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unexposed</arm_group_label>
    <description>In each study the unexposed group will consist of tobacco user from the study cohort without the condition examined in the relevant study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco cessation intervention</intervention_name>
    <description>Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden</description>
    <arm_group_label>Exposed</arm_group_label>
    <arm_group_label>Unexposed</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The population in this study are tobacco users in Sweden, who have attented an in-person&#xD;
        tobacco cessation programme.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult tobacco users (of at least 18 years of age), including disadvantaged and&#xD;
             vulnerable patients, receiving an in-person intervention (incl. online meetings) for&#xD;
             tobacco cessation (smoking, snus and/or e-cigarettes) are eligible for inclusion in&#xD;
             the project after giving informed consent.&#xD;
&#xD;
          -  Both individual and group-based interventions can be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Withdrawing consent.&#xD;
&#xD;
          -  Reduced ability to give informed consent, due to inadequate language skills, dementia,&#xD;
             and other conditions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanne Tønnesen, DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University, Clinical health promotion centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mette Rasmussen, PhD</last_name>
    <phone>+4538163850</phone>
    <email>mette.rasmussen@med.lu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hanne Tønnesen, DSc</last_name>
    <phone>+46724531481</phone>
    <email>hanne.tonnesen@med.lu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tobaksavvänjningen, Kirurgisk mott., CLV Växjö lasarett</name>
      <address>
        <city>Växjö</city>
        <state>Kronoberg</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Uneklint</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Capio Go</name>
      <address>
        <city>Malmö</city>
        <state>Skåne Län</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A Karlsson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Livsstilsmedicin Österåsen</name>
      <address>
        <city>Sollefteå</city>
        <state>Västernorrland</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A Mähler</last_name>
    </contact>
    <contact_backup>
      <last_name>A Stenius</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ekeby Hälsocenter</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>K Brudin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flogsta vårdcentral</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I Granlund</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tobakspreventiva enheten, USÖ</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Larsson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tybble vårdcentral</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Larsson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tobakspreventiv mottagning Karlskoga</name>
      <address>
        <city>Karlskoga</city>
        <state>Örebro Län</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Randén</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://www.rokstoppsprojektet.org</url>
    <description>The Swedish national public homepage of the project</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lund University</investigator_affiliation>
    <investigator_full_name>Hanne Tonnesen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>National cohort study</keyword>
  <keyword>Effectiveness</keyword>
  <keyword>Tobacco use cessation</keyword>
  <keyword>Smoking cessation</keyword>
  <keyword>Vulnerable groups</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

